• About Pharmetheus
    • History
    • Mission & Values
    • Leadership
    • Scientific advisors
    • Our team
    • Social impact (CSR)
    • Contexts of use
      • Trial design and analysis
      • Program strategies and efficiences
      • Special/specific populations
      • Special considerations
      • Regulatory interactions
    • Pharmetheus Platforms
      • Model-Informed Drug Development
      • PBPK & PBBM
      • Pharmacometrics
      • QSP
    • Solutions
      • Milestone Analysis
      • Embedded Scientists
      • Expert Advice
      • Scientific Publication
    • Specific services
      • Model-Informed Bioequivalence 
& Biosimilarity
      • Accelerated submission
      • Concentration-QTc (C-QTc) modeling
      • Data-driven strategies for pediatric success
      • Training workshops
      • Publications
      • Case studies
      • Articles
    • Working with us
    • Open positions
    • Employee stories
    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Viviana Moroso brings scientific depth to quality control

    Viviana Moroso brings scientific depth to quality control

    Siv Jönsson develops Pharmetheus’s learning agenda

    Siv Jönsson develops Pharmetheus’s learning agenda

  • Events
  • News
  • Contact us
  1. Home
  2. Events
  3. Pharmetheus at Open Systems Pharmacology Community Conference 2026

Pharmetheus at Open Systems Pharmacology Community Conference 2026

Join the Open Systems Pharmacology (OSP) community in Belgium for our 3rd annual gathering! This two-day conference brings together modelers, researchers, and developers to share the latest advancements in PBPK, QSP, and open-source computational tools driving drug development.

Book a meeting

IS_16x9_Pharmetheus_06_ExpertAdvice_A-1.png

We’d love to meet you — whether you’re curious about who we are, or wish to explore the services we offer, we’re here to help.

Schedule a meeting with us

Scientific contributions

Presentations

Development of a PBBM Integrating the Particle Drifting Effect for Predictions of Oral Absorption of Nanoparticle Formulations in Human

Paul Vrenken

Elevating PBPK as Primary Evidence: A Collaborative Best-Practice Framework for Regulatory Qualification and ICH M15 Alignment

Marylore Chenel, Andre Dallmann

Benchmarking a Mechanistic Anti-Drug Antibody (ADA) Predictor: Bridging Sequence-based Prediction with Clinical Data

Gianluca Selvaggio

Posters

Demystifying OATP1B1/3 Drug-Drug Interactions: An Open-Source PBPK Model for Coproporphyrin-I in the Open Systems Pharmacology Suite

Tobias Kanacher, Moriah Pellowe, Christina Kovar, Johanna Eriksson, Jing Wu, David Busse, Jose David Gómez-Mantilla, Peter Stopfer, Ibrahim Ince, Fenglei Huang

Our team on site

Chief Research Officer

Marylore Chenel

Senior Director, MIDD Consultant

Johanna Eriksson

Senior Director, MIDD Consultant

Tobias Kanacher

Principal Director, PBPK & PBBM Scientific Lead

Erik Sjögren

Associate, MIDD Consultant

Paul Vrenken

Get in touch

Related events


Contact

Pharmetheus AB
Kungsängstull 4 

753 19 Uppsala, Sweden

Visiting address: 

Dragarbrunnsgatan 77, 5th floor

  • LinkedIn
  • YouTube
  • Science & Services
    • Contexts of use
    • Pharmetheus Platforms
    • Solutions
    • Specific services
    • Publications
    • Case studies
  • Quick links
    • About us
    • Events
    • News
    • Careers
    • Contact us
    • Newsletter

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Gasell 2017
Gasell 2020
Gasell 2021
Gasell 2022
Gasell 2023
Gasell 2024

Copyright © Pharmetheus AB 2026

  • Whistleblower
  • Privacy Policy
  • Cookie Policy